Lymphocyte subpopulation reference ranges for monitoring human eficiency virus-infected Chinese adults

Clinical and Diagnostic Laboratory Immunology

Volumn 3, Issue 3, 1996, Pages 326-330

  Kam, Kai Man ^a   Leung, Wai Lin ^a   Kwok, Mei Yee ^a   Hung, Mi Yim ^a   Lee, Shui Shan ^b   Mak, Wai Ping ^a  

^a Institute of Pathology   (Hong Kong)

^b Yaumati Polyclinic   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHINA; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE SUBPOPULATION; NATURAL KILLER CELL; NORMAL HUMAN; NORMAL VALUE; PHENOTYPE; PRIORITY JOURNAL; QUALITY CONTROL;

EID: 0029937070     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.3.3.326-330.1996     Document Type: Article

References (24)

1. Association of State and Territorial Public Health Laboratory Directors. 1991. Report and recommendations. Flow cytometry, p. 17-19. Sixth Annual Conference on Human Retrovirus Testing, Kansas City, Mo.
2. Babcock, G. F., A. F. Taylor, B. A. Hynd, et al. 1987. Flow cytometric analysis of lymphocyte subset phenotypes comparing normal children and adults. Diagn. Clin. Immunol. 5:175-179.
3. Blumberg, R. S., and R. T. Schooley. 1985. Lymphocyte markers and infectious diseases. Semin. Hematol. 22:81-114.
4. Centers for Disease Control and Prevention. 1992. Recommendations for prophylaxis against Pneumocystis carinii pneumonia for adults and adolescents infected with human immunodeficiency virus. Morbid. Mortal. Weekly Rep. 41 (no. RR-4):1-11.
5. Centers for Disease Control and Prevention. 1992. Guidelines for the performance of CD4+ T-cell determinations in persons with human immunodeficiency virus infection. Morbid. Mortal. Weekly Rep. 41 (no. RR-8):1-17.
6. Centers for Disease Control and Prevention. 1992.1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morbid. Mortal. Weekly Rep. 41(no. RR-17):1-19.
7. Ekong, T., E. Kupek, A. Hill, C. Clark, A. Davies, and A. Pinching. 1993. Technical influences on immunophenotyping by flow cytometry. The effect of time and temperature of storage on the viability of lymphocyte subsets. J. Immunol. Methods 164:263-273.
8. Gelman, R., S. C. Cheng, P. Kidd, M. Waxdal, and J. Kagan. 1993. Assessment of the effects of instrumentation, monoclonal antibody, and flurochrome on flow cytometric immunophenotyping: a report based on 2 years of the NIAID DAIDS flow cytometry quality assessment program. Clin. Immunol. Immunopathol. 66:150-162.
9. Global Programme on AIDS. 1993. The HIV/AIDS pandemic: 1993 overview. World Health Organization, Geneva.
10. Hannet, I., F. Erkeller-Yuksel, P. Lydyard, et al. 1992. Development and maturational changes in human blood lymphocyte subpopulations. Immunol. Today 13:215-218.
11. Kestens, L., G. Vanham, P. Gigase, G. Young, I. Hannet, F. Vanlangendonck, F. Hulstaert, and B. A. Bach. 1992. Expression of activation antigens, HLA-DR and CD38, on CD8 lymphocytes during HIV-1 infection. AIDS 6:793-797.
12. Laurence, J. 1993. T-cell subsets in health, infectious disease, and idiopathic CD4+ T lymphopenia. Ann. Intern. Med. 119:55-62.
13. Loken, M. R., J. M. Brosnan, B. A. Bach, and K. A. Ault. 1990. Establishing optimal lymphocyte gates for immunophenotyping by flow cytometry. Cytometry 11:453-459.
14. Matsumoto, K., K. Okubo, and M. Yokoyama. 1985. Distribution of marker-specific lymphocyte subsets in healthy human subjects. J. Clin. Lab. Immunol. 16:143-147.
15. Nagel, J., F. Chrest, R. S. Pyle, and W. H. Adler. 1983. Monoclonal antibody analysis of T lymphocyte subsets in young and aged humans. Immunol. Commun. 12:223-237.
16. National Committee for Clinical Laboratory Standards. 1992. Clinical applications of flow cytometry. Quality assurance and immunophenotyping of peripheral blood lymphocytes. NCCLS publication H24-T. National Committee for Clinical Laboratory Standards, Villanova, Pa.
17. National Institutes of Health. 1990. Recommendations for zidovudine: early infection. JAMA 263:1606, 1609.
18. Parker, J. W., B. Adelsberg, S. P. Azen, et al. 1990. Leukocyte immunophenotyping by flow cytometry in a multisite study: standardization, quality control, and normal values in the transfusion safety study. Clin. Immunol. Immunopathol. 55:187-220.
19. Prince, H. E., H. Karim, L. S. Waldbeser, S. Plaeger-Marshall, S. Kleinman, and L. L. Lanier. 1985. Influence of racial background on the distribution of T-cell subsets and Leu 11-positive lymphocytes in healthy blood donors. Diagn. Immunol. 3:33-37.
20. Reichert, T., M. DeBruyerc, V. Deneys, et al. 1991. Lymphocyte subset reference ranges in adult Caucasians. Clin. Immunol. Immunopathol. 60:190-208.
21. Rickman, W. J., M. J. Waxdal, C. Monical, et al. 1989. Department of Army lymphocyte immunophenotyping quality assurance program. Clin. Immunol. Immunopathol. 52:85-95.
22. World Health Organization. 1992. Unexplained severe immunosuppression without evidence of HIV infection. W. H. O. Weekly Epidemiol. Rec. 42:309-311.
23. World Health Organization. 1994. WHO case definitions for AIDS surveillance in adults and adolescents. W. H. O. Weekly Epidemiol. Rec. 69:273-275.
24. World Health Organization. 1995. WHO AIDS data at 31st December 1994 and the current global situation of the HIV/AIDS pandemic. W. H. O. Weekly Epidemiol. Rec. 70:5-8.